Abstract
We report the results of an observer blind crossover trial in 31 patients with essential hypertension comparing the hypotensive effect of four doses of prazosin and of hydralazine used as the third step of triple therapy and additional data on the efficacy of low dose combinations of these two drugs. Both drugs had an appreciable antihypertensive effect, 1 mg of prazosin being equivalent to 12.5 mg of hydralazine. Increasing the dose of prazosin from 4 to 8 mg twice daily and hydralazine from 50 to 100 mg twice daily did not consistently reduce blood pressure. The combination of the two drugs at low doses resulted in the blood pressure of more patients being controlled (diastolic blood pressure 90 mm Hg or below) than when either drug was used alone at high dose. The symptoms reported by patients were similar for both drugs. The combination did not lead to an increased reporting frequency. The trial demonstrates one of the problems of a crossover study, namely a treatment/period interaction.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronow W. S., Van Herick R., Greenfield R., Alimadadian H., Burwell D., Mann W. Effect of timolol plus hydrochlorothiazide plus hydralazine on essential hypertension. Circulation. 1978 May;57(5):1017–1021. doi: 10.1161/01.cir.57.5.1017. [DOI] [PubMed] [Google Scholar]
- Bannan L. T., Beevers D. G., Wright N. ABC of blood pressure reduction. Drug treatment. Br Med J. 1980 Oct 11;281(6246):982–984. doi: 10.1136/bmj.281.6246.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kincaid-Smith P., Hua A. S., Myers J. B., MacDonald I., Fang P. Prazosin and hydrallazine in the treatment of hypertension. Clin Sci Mol Med Suppl. 1976 Dec;3:617s–619s. doi: 10.1042/cs051617s. [DOI] [PubMed] [Google Scholar]
- Marshall A. J., Barritt D. W., Pocock J., Heaton S. T. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. Lancet. 1977 Feb 5;1(8006):271–274. doi: 10.1016/s0140-6736(77)91822-0. [DOI] [PubMed] [Google Scholar]
- Ramsay L. E. Diuretic and beta-blocker in hypertension--then what? J R Coll Physicians Lond. 1980 Oct;14(4):249–253. [PMC free article] [PubMed] [Google Scholar]
- Russell G. I., Swart S., Bing R. F., Thurston H., Swales J. D. Combined prazosin and hydralazine in resistant hypertension. Lancet. 1980 Mar 8;1(8167):543–543. doi: 10.1016/s0140-6736(80)92796-8. [DOI] [PubMed] [Google Scholar]
- Wilcox R. G., Mitchell J. R. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension. Br Med J. 1977 Aug 27;2(6086):547–550. doi: 10.1136/bmj.2.6086.547. [DOI] [PMC free article] [PubMed] [Google Scholar]